Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 57   

Articles published

THRX 26.47 -0.66 (-2.43%)
price chart
Theravance Is A Classic Ben Graham Bargain
Within a few weeks, Theravance (THRX) will split into two distinct companies: Royalty Management will retain the net operating loss carryforwards, the three programs partnered with GSK and 15% of all other programs the current Theravance is developing.
Theravance: Baby Thrown Out With The Bath Water - 35% To 65% Upside
Theravance (THRX) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous ...
Theravance Inc.: Theravance to Report First Quarter 2014 Financial Results on ...
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/15/14 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended March 31, 2014 after market close on Tuesday, May 6, 2014.
Anoro Ellipta by GlaxoSmithKline and Theravance, Inc
The FDA has approved Anoro Ellipta (GlaxoSmithKline and Theravance, Inc) for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
Related articles »  
Theravance Inc.: Theravance Appoints Kevin Kwok, Head of Talent Acquisition ...
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/01/14 -- Theravance, Inc. (the "Company") (NASDAQ: THRX) announced today the appointment of Kevin Kwok as Head of Talent Acquisition and Strategy.
Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy  MarketWatch
Related articles »  
Stocks in the News - Theravance Inc (NASDAQ:THRX), Laboratory Corp. of ...
Theravance Inc (NASDAQ:THRX) remained among the day bears with 0.07% and traded with volume of 1.24 million shares in the last session, as compared to average volume of 1.05 million shares.
Hot Stock's Alert � Theravance Inc(THRX) Dresser-Rand Group Inc.( DRC ...
Birmingham, West Midlands - (TechSonian) - 02/04/2014 �Theravance Inc (THRX) released recently that the appointment of Kevin Kwok as Head of Talent Acquisition and Strategy.
Biotech Stocks Coverage -- Research on Seattle Genetics, Theravance ...
Investor-Edge has initiated coverage on the following equities: Seattle Genetics Inc. (NASDAQ: SGEN), Theravance Inc. (NASDAQ: THRX), Neurocrine Biosciences Inc. (NASDAQ: NBIX) and MiMedx Group Inc. (NASDAQ: MDXG).
Related articles »  
Hot Stocks-ARRIS Group, Inc. (NASDAQ:ARRS), Theravance Inc (NASDAQ ...
Theravance Inc. (THRX) declared the initiation of the dose-ranging Phase 2b Study 0117 with TD-4208 as a nebulized aqueous solution in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Related articles »  
Stocks on Trader's Radar-Hanwha Solarone (HSOL), Theravance THRX), Qlik ...
Theravance Inc. (THRX) declared the selection of Kevin Kwok as Head of Talent Acquisition and Strategy. Dr. Kwok will be responsible for leading the Company's efforts in talent acquisition and talent management and implementation of the strategies in ...
Related articles »